ARCHIVES

Special Report: KRAS Finding Changes Oncology Practice But Poses Profound Regulatory Dilemma

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Early ADT Doesn’t Offer Survival Advantage—ASCO

April 27, 2007

HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials

May 21, 1982

NCI Treatment Division To Recompete $10 Million In Resource Contracts; Board Okays New Projects

November 12, 1976

NCAB Asks For Cost Reimbursement n Patients In Clinical Trials Until More Data Available

October 5, 1984

House Committee Approves $1.9 Bil. NCI Budget

July 31, 1992

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998